1. Introduction
Extramammary Paget disease is a rare, slow-growing intraepithelial adenocarcinoma that presents in regions of the skin rich in apocrine glands. While it shares identical cellular characteristics with mammary Paget disease of the breast, this specific condition occurs entirely outside the anatomical boundaries of the breast tissue. The disease most frequently manifests in the anogenital regions, specifically the vulva, the perianal area, the scrotum, and the penis, though it can occasionally appear in the axillae (armpits).
The clinical presentation often mimics chronic, benign dermatological conditions, frequently leading to a prolonged delay in obtaining a definitive diagnosis. Understanding the distinction between primary extramammary disease, which originates entirely within the epidermis, and secondary disease, which is associated with an underlying visceral or adnexal malignancy, is of paramount importance. Comprehensive clinical evaluation and precise surgical intervention are required to manage the localized symptoms and mitigate the risk of underlying systemic disease.
2. Cellular Pathophysiology
The defining biological characteristic of the condition is the presence of Paget cells within the squamous epithelium of the skin. Under microscopic evaluation, these specialized neoplastic cells appear large and round, possessing abundant pale cytoplasm and prominent, atypical nuclei. They proliferate within the epidermal layer, disrupting the normal cellular architecture and compromising the skin’s barrier function.
The origin of these cells defines the primary versus secondary nature of the disease. In primary extramammary Paget disease, the malignant cells are believed to arise directly from intraepidermal pluripotent stem cells or from the superficial portions of the local apocrine sweat gland ducts. The disease remains localized to the epidermis as an in situ carcinoma for a prolonged period, expanding horizontally across the skin surface before ever acquiring the capability for deeper stromal invasion.
3. Secondary Extramammary Disease
A critical clinical consideration is the phenomenon of secondary extramammary Paget disease. In a subset of patients, the Paget cells in the skin represent an epidermotropic migration of cells from an underlying, separate malignancy. This mechanism is identical to how mammary Paget disease results from an underlying breast cancer.
Depending on the anatomical location of the skin lesion, the underlying malignancy could be an adnexal skin appendage tumor, a colorectal adenocarcinoma (especially with perianal presentation), or a urothelial carcinoma of the bladder or urethra. Identifying whether the skin condition is primary or secondary is the most crucial step in the diagnostic pathway, as an associated visceral malignancy fundamentally alters the systemic prognosis and treatment strategy.
4. Clinical Presentation and Symptoms
Patients typically present with chronic, persistent, and highly localized skin changes in the anogenital or axillary regions. The lesions frequently appear as well-demarcated, erythematous (red), and scaly plaques. The affected skin often looks thickened, macerated, and occasionally exhibits a weeping or crusted surface, closely resembling severe eczema, contact dermatitis, or a superficial fungal infection.
Intense pruritus, or severe localized itching, is the most common presenting symptom. Because the affected areas are subject to friction and moisture, secondary bacterial or fungal infections frequently complicate the presentation. A defining clinical feature is that these lesions fail to resolve despite the prolonged application of standard topical corticosteroids or antifungal medications, a failure that should immediately prompt a specialized biopsy.
5. Diagnostic Biopsy and Histology
The definitive diagnosis relies entirely on a deep punch biopsy or incisional biopsy of the affected skin. The dermatopathologist carefully analyzes the tissue to identify the classic large, pale Paget cells scattered individually or in small clusters within the normal epidermal layers.
To confirm the diagnosis and assist in distinguishing primary from secondary disease, immunohistochemical staining is utilized. Primary extramammary Paget cells typically express specific cytokeratins (such as CK7) while testing negative for others (such as CK20). Conversely, if the cells test positive for CK20, it strongly suggests a secondary disease origin, pointing toward an underlying gastrointestinal or urothelial malignancy that requires immediate investigation.
6. Comprehensive Clinical Staging
Upon histological confirmation of extramammary Paget disease, a rigorous systemic evaluation is mandated to rule out an associated underlying malignancy. The extent of this evaluation is tailored to the anatomical location of the skin lesion.
For perianal presentations, a comprehensive colonoscopy and lower gastrointestinal evaluation are essential. For vulvar, scrotal, or penile presentations, a detailed urological assessment, including cystoscopy, and a thorough gynecological examination are required. Radiological imaging, such as a computed tomography scan of the abdomen and pelvis, is frequently utilized to complete the systemic staging and ensure no occult adnexal or visceral tumors are present.
7. Differential Diagnosis Challenges
Differentiating this rare carcinoma from common, benign skin conditions is critical to minimize diagnostic delays.
| Condition | Distinguishing Characteristics |
|---|---|
| Eczema or Contact Dermatitis | Typically resolves quickly with the appropriate application of topical corticosteroid therapy. |
| Extramammary Paget Disease | Persistent, erythematous, and weeping plaques that are wholly unresponsive to standard topical dermatological treatments. |
| Squamous Cell Carcinoma in Situ (Bowen’s Disease) | Often presents as a scaly, red patch but lacks the specific large, pale Paget cells upon microscopic biopsy review. |
8. Primary Surgical Management
For primary, non-invasive extramammary Paget disease, surgical extirpation is the standard and most effective therapeutic modality. The surgical objective is the complete removal of the affected epidermal tissue with clear, negative microscopic margins.
Achieving clear margins is notoriously difficult. The disease frequently exhibits subclinical extension, meaning the malignant cells proliferate horizontally through the epidermis far beyond the visually apparent red borders of the skin lesion. Consequently, standard wide local excision is associated with a high rate of local recurrence due to unrecognized positive margins.
9. Mohs Micrographic Surgery
To address the challenge of subclinical extension, Mohs micrographic surgery is frequently employed as the optimal surgical technique. This highly specialized procedure involves removing the visible lesion and sequentially excising very thin layers of the surrounding skin.
Each layer is immediately mapped and examined microscopically in real-time by the surgeon while the patient remains in the operating room. This precise tissue-sparing technique ensures that 100% of the surgical margin is evaluated, significantly increasing the probability of complete disease eradication while preserving the maximum amount of healthy, unaffected tissue in anatomically sensitive areas.
10. Non-Surgical Therapeutic Alternatives
In specific clinical scenarios where surgical resection is contraindicated due to patient comorbidities, or when the anatomical location renders extensive surgery unfeasible, non-surgical alternatives may be considered. These treatments aim for disease control rather than definitive surgical cure.
Topical immunomodulators, such as imiquimod cream, can be utilized to stimulate the localized immune system to attack the neoplastic cells. Alternatively, photodynamic therapy, which utilizes a photosensitizing agent activated by a specific wavelength of light to destroy abnormal cells, may be employed. However, these localized medical treatments generally exhibit higher recurrence rates compared to meticulous surgical excision.
11. Radiation Therapy Considerations
Radiation therapy serves a highly specialized role in the management algorithm. It is typically reserved for elderly patients who are poor surgical candidates, for lesions that are too extensive for complete resection without massive morbidity, or as an adjuvant treatment following surgery if the final microscopic margins are positive for residual disease.
Targeted ionizing radiation effectively destroys the proliferating intraepidermal cells. The radiation oncologist carefully calibrates the dosage to minimize significant toxicity to the delicate surrounding skin and underlying mucous membranes of the anogenital region.
12. Management of Secondary Disease
If the systemic evaluation reveals an underlying adnexal or visceral malignancy, the treatment paradigm shifts dramatically. The primary therapeutic focus must immediately pivot to aggressively managing the deeper, invasive cancer.
The localized skin condition becomes a secondary concern. Systemic chemotherapy, extensive surgical resections (such as bowel or bladder resection), and systemic radiation are deployed based on the specific staging and biological characteristics of the underlying primary internal tumor.
13. Reconstructive Interventions
Following extensive surgical resection in the anogenital or axillary regions, reconstructive surgery is frequently necessary to restore anatomy and function. Plastic surgeons collaborate closely with the oncological team to repair the resulting tissue defects.
Techniques utilize localized tissue advancements or complex skin grafting procedures to ensure tension-free closure, promote optimal wound healing, and maintain the functional integrity of the surrounding sphincter complexes and genitourinary structures.
14. Long-Term Prognosis
The clinical prognosis for patients with primary, non-invasive extramammary Paget disease is generally excellent regarding overall survival, as the disease rarely metastasizes if it remains confined to the epidermis. However, the condition is notorious for frequent local recurrences, necessitating lifelong vigilance.
Conversely, the prognosis for secondary extramammary Paget disease is heavily dependent on the stage and aggressiveness of the associated underlying internal malignancy, which carries a significantly higher risk of systemic morbidity and mortality.
15. The Importance of Multidisciplinary Care
The anatomical complexity and varied etiology of this condition necessitate a highly coordinated multidisciplinary approach. Dermatologists, dermatopathologists, surgical oncologists, urologists, gynecologists, and gastroenterologists must collaborate effectively.
This unified clinical strategy ensures accurate histopathological diagnosis, thorough systemic evaluation to rule out secondary malignancies, and the execution of a tailored, tissue-sparing treatment plan that prioritizes complete disease control and optimal patient quality of life.
16. Continuous Surveillance
Post-treatment survivorship requires a strict, structured schedule of continuous clinical surveillance. Patients undergo frequent, meticulous visual and tactile examinations of the previously affected skin and surrounding apocrine-rich areas.
Because local recurrence can occur many years after the initial surgical intervention, this vigilant monitoring is maintained indefinitely. Early detection of any subtle skin changes ensures prompt re-intervention, maintaining long-term localized disease control.
17. Frequently Asked Questions (FAQ)
1. Why was this condition initially misdiagnosed as severe eczema?
Because the superficial skin changes—redness, scaling, and itching—are visually identical to common benign skin conditions. It is only when the rash completely fails to respond to prolonged steroid cream usage that a specialized biopsy is performed, revealing the true cellular diagnosis.
2. Does having this skin condition mean I have an internal cancer?
Not necessarily. In the majority of cases, the condition is “primary,” meaning the abnormal cells are isolated only to the top layer of the skin. However, your physician will perform comprehensive testing (like a colonoscopy or cystoscopy) strictly to rule out any associated internal issues.
3. Why is Mohs surgery recommended instead of standard surgery?
The abnormal cells frequently spread invisibly through the skin far beyond the red borders of the visible rash. Mohs surgery allows the surgeon to check every single edge of the removed tissue under a microscope in real-time, ensuring all invisible cells are eradicated while sparing healthy tissue.
4. Will the intense itching stop after the surgery?
Yes. The localized pruritus (itching) is a direct symptom of the abnormal cells disrupting the normal skin layer. Once the affected tissue is completely removed through surgery, the intense itching will resolve.
18. Bibliography
Disclaimer: The content is for informational purposes only and does not replace medical advice. Always consult your doctor for personalized treatment.
